Results 91 to 100 of about 17,734 (168)
We analyzed the methylation status of the 06-methylguanine-DNAmethyltransferase (MGMT) promoter and mRNA expression in HL cells and assessed the response of these cells to dacarbazine.
Kewitz, Stefanie +3 more
core +1 more source
Background: Malignant melanoma is a highly malignant tumor that results from the malignant transformation of melanocytes. It is mainly accompanied by changes in the immune microenvironment and severe intra-tumor vascular abnormalities, which ...
Yueling Yang +8 more
doaj +1 more source
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible ...
Françoise Descotes (366487) +8 more
core +1 more source
Dacarbazine mediate antimelanoma effects via NK cells.
International audienceMelanoma is a highly chemoresistant and metastatic tumor that, in the absence of BRAF mutations, is generally treated with the alkylating agent dacarbazine (DTIC).
Hervieu, Alice +2 more
core +1 more source
Objective: While there are significant ongoing advancements in the management of Hodgkin lymphoma, doxorubicin + bleomycin + vinblastine + dacarbazine remains a preferred option for early stage Hodgkin lymphoma and is a frequently used first-line ...
Eugene Chao +3 more
doaj +1 more source
The German Hodgkin Study Group developed the escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) protocol as a treatment strategy for advanced-stage Hodgkin's lymphoma.
Larissa Hilario Dulley +5 more
doaj +1 more source
Background and Purpose: Cancer is a serious public health concern, hence the determination of dacarbazine as a significant chemotherapeutic agent is very important.
Somayeh Tajik +4 more
doaj +1 more source
An ELISA method was used to determine N7-methylguanine (N7-MeGua) adducts in DNA of white blood cells from cancer patients treated with the methylating antitumor drug dacarbazine by i.v. administration.
Ende, A.M.C. van den +4 more
core
Metastatic melanomas are highly aggressive and median survival is 6-9. months for stage IV patients in the absence of treatment with anti-tumor activity.
Goormaghtigh, Erik +9 more
core +1 more source
Insulin induces drug resistance in melanoma through activation of the PI3K/Akt pathway
Mengna Chi,1 Yan Ye,1 Xu Dong Zhang,1 Jiezhong Chen2,3 1School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; 2School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia; 3Faculty of ...
Chi M, Ye Y, Zhang XD, Chen J
doaj

